Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In Vitro
Direct reprogramming of somatic cells into pluripotent cells by retrovirus-mediated expression of OCT4, SOX2, KLF4, and C-MYC is a promising approach to derive disease-specific induced pluripotent stem cells (iPSCs). In this study, we focused on three murine models for metabolic liver disorders: the...
Saved in:
Main Authors: | Reto Eggenschwiler, Komal Loya, Malte Sgodda, Francoise André, Tobias Cantz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.4061/2011/924782 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient-Specific Pluripotent Stem Cells in Neurological Diseases
by: Serpen Durnaoglu, et al.
Published: (2011-01-01) -
Highly Synchronized Expression of Lineage-Specific Genes during In Vitro Hepatic Differentiation of Human Pluripotent Stem Cell Lines
by: Nidal Ghosheh, et al.
Published: (2016-01-01) -
Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34pos Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction
by: Mohsen Moslem, et al.
Published: (2015-01-01) -
Induced Pluripotent Stem Cells and Outer Retinal Disease
by: Jin Yang, et al.
Published: (2016-01-01) -
Lack of Disease Specificity Limits the Usefulness of In Vitro Costimulation in HIV- and HCV-Infected Patients
by: Stefanie Kuerten, et al.
Published: (2008-01-01)